0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
API Holdings, the parent company of PharmEasy, is set to raise Rs 1,700 crore ($193 million) through redeemable non-convertible debentures (NCDs), pledging the shares of its listed diagnostics subsidiary Thyrocare.
Share this article
If you liked this article share it with your friends.they will thank you later